Acumen Pharmaceuticals (ABOS)
NASDAQ:ABOS
US Market
Holding ABOS?
Track your performance easily

Acumen Pharmaceuticals (ABOS) Technical Analysis

403 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
4Neutral
4Bearish
Technical Analysis Consensus
Sell
2Bullish
4Neutral
4Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Acumen Pharmaceuticals’s (ABOS) Moving Averages Convergence Divergence (MACD) indicator is 0.16, suggesting Acumen Pharmaceuticals is a Sell.
Acumen Pharmaceuticals’s (ABOS) 20-Day exponential moving average is 2.84, while Acumen Pharmaceuticals’s (ABOS) share price is $3.17, making it a Buy.
Acumen Pharmaceuticals’s (ABOS) 50-Day exponential moving average is 2.71, while Acumen Pharmaceuticals’s (ABOS) share price is $3.17, making it a Buy.

Acumen Pharmaceuticals (ABOS) Pivot Points

Nov 08, 2024, 10:51 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.51
2.68
2.96
3.13
3.40
3.57
3.84
Fibonacci
2.68
2.85
2.96
3.13
3.29
3.40
3.57
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Acumen Pharmaceuticals (ABOS) Moving Averages

Nov 08, 2024, 10:51 AM
Period
Simple
Exponential
MA5
3.04Buy
3.08Buy
MA10
2.98Buy
2.98Buy
MA20
2.78Buy
2.84Buy
MA50
2.58Buy
2.71Buy
MA100
2.66Buy
2.75Buy
MA200
3.09Buy
2.98Buy
Acumen Pharmaceuticals’s (ABOS) 10-Day exponential moving average is 2.98, while Acumen Pharmaceuticals’s (ABOS) share price is $3.17, making it a Buy.
Acumen Pharmaceuticals’s (ABOS) 100-Day exponential moving average is 2.75, while Acumen Pharmaceuticals’s (ABOS) share price is $3.17, making it a Buy.
Acumen Pharmaceuticals’s (ABOS) stock price is $3.17 and Acumen Pharmaceuticals’s (ABOS) 50-day simple moving average is 2.58, creating a Buy signal.
Acumen Pharmaceuticals’s (ABOS) stock price is $3.17 and Acumen Pharmaceuticals’s (ABOS) 100-day simple moving average is 2.66, creating a Buy signal.
Acumen Pharmaceuticals’s (ABOS) stock price is $3.17 and Acumen Pharmaceuticals’s (ABOS) 200-day simple moving average is 3.09, creating a Buy signal.

Acumen Pharmaceuticals (ABOS) Technical Indicators

Nov 08, 2024, 10:51 AM
Name
Value
Implied Action
RSI (14)
65.97
Neutral
STOCH (9,6)
78.23
Neutral
STOCHRSI (14)
84.75
Sell
MACD (12,26)
0.16
Sell
ADX (14)
35.11
Neutral
Williams %R
-17.99
Sell
CCI (14)
140.56
Sell
ATR (14)
0.20
-
Ultimate Oscillator
54.35
Neutral
ROC
10.84
Buy
Acumen Pharmaceuticals’s (ABOS) Relative Strength Index (RSI) is 65.97, creating a Neutral signal.
Acumen Pharmaceuticals’s (ABOS) Trend Strength Indicator (ADX) is 35.11, creating a Neutral signal.
Acumen Pharmaceuticals’s (ABOS) Commodity Channel Index (CCI) is 140.56, creating a Sell signal.
Acumen Pharmaceuticals’s (ABOS) Price Rate of Change (ROC) is 10.84, creating a Buy signal.

FAQ

Is ABOS a Buy, Hold, or Sell?
Based on ABOS’s technical indicators, ABOS is a Buy.
    What is ABOS’s RSI (14)?
    ABOS’s RSI (14) is 65.97, which suggests ABOS is a Neutral.
      What is ABOS’s MACD?
      ABOS’s MACD is 0.16, which suggests ABOS is a Sell.
        What is ABOS’s 5-day moving average?
        ABOS’s 5-day moving average is 3.04, which suggests ABOS is a Buy.
          What is ABOS’s 20-day moving average?
          ABOS 20-day moving average is 2.78, which suggests ABOS is a Buy.
            What is ABOS’s 50-day moving average?
            ABOS’s 50-day moving average is 2.58, which suggests ABOS is a Buy.
              What is ABOS’s 200-day moving average?
              ABOS’s 200-day moving average is 3.09, which suggests ABOS is a Buy.
                What is ABOS’s Williams % R (14)?
                ABOS’s Williams % R (14) is -17.99, which suggests ABOS is a Sell.
                  What is ABOS’s CCI (14)?
                  ABOS’s CCI (14) is 140.56, which suggests ABOS is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis